
ABSTRACT This article describes the development of aortic valve-sparing operations and their current status in surgical practice. They are classified into two general types of operations: aortic root remodeling and aortic valve reimplantation. Both techniques have been modified over the years from their original descriptions, but both remain useful in appropriately selected patients with aortic root and proximal aortic aneurysms, provided the aortic valve cusps are reasonable. Aortic valve reimplantation has proven more durable in young patients with aortic root aneurysms associated with genetic syndromes, whereas remodeling of the aortic root may be appropriate for older patients with ascending aortic aneurysms, dilated sinotubular junction, and secondarily dilated aortic sinuses. These operations were developed to preserve the native aortic valve and have expanded the armamentarium to treat patients with aortic root aneurysms and reasonably normal aortic cusps. In addition to a description of their development, a summary of current results of aortic valve reimplantation worldwide is presented, along with the author’s personal perspective on its reproducibility.
ABSTRACT Ionizing radiation is associated with an increased risk of malignancy, especially in fetuses. Therefore, in the rare situation of a pregnant patient in need of a pacemaker, alternatives to conventional fluoroscopy are required. We describe a case of successful implantation of a Ventricle-paced, Dual-sensing, Dual-response pacemaker without fluoroscopy in a 32-year-old female patient using electroanatomic 3D mapping. She had severe bradycardia due to complete atrioventricular block, which impeded intrauterine growth restriction in the fetus.
ABSTRACT Introduction: The myocardial ischemia-reperfusion injury (IRI) is an indispensable factor in pediatric congenital heart defect (CHD) surgery. Although effective myocardial protection strategies are crucial, the issue remains a dilemma. This study aimed to evaluate the effect of adding dexmedetomidine to modified Del Nido cardioplegia on myocardial protection in children undergoing CHD surgery. Methods: This was a prospective, randomized, triple-blind, controlled clinical trial. A total of 60 pediatric patients were enrolled and randomized 1:1 into two groups - an intervention group that received dexmedetomidine-enriched modified Del Nido cardioplegia and a control group that received standard modified Del Nido cardioplegia with normal saline. Primary outcomes included serum troponin I and creatine kinase-MB levels, as well as coronary sinus lactate levels. Secondary outcomes were the vasoactive-inotropic score, weaning time from mechanical ventilation, and intensive care unit length of stay. Results: Adding dexmedetomidine to modified Del Nido cardioplegia significantly improved myocardial protection in children undergoing CHD surgery. The intervention group showed significantly lower troponin I levels at all postoperative time points compared to the control group (P < 0.001). Similarly, the dexmedetomidine group had significantly lower vasoactive-inotropic score at all time points (P < 0.001). Patients in the intervention group also experienced a significantly shorter mean ventilator weaning time (P < 0.001) and intensive care unit stay duration (P < 0.001). The overall distribution of postoperative morbidities did not differ significantly between the groups (P = 0.059). Conclusion: Adding dexmedetomidine to modified Del Nido cardioplegia significantly improved myocardial protection in children undergoing corrective CHD surgery.
Introduction: This retrospective study evaluated the feasibility, safety, and early recovery outcomes of intraoperative extubation combined with minimally invasive axillary thoracotomy for atrial septal defect (ASD) and ventricular septal defect (VSD) repair in pediatric patients. Methods: Sixty-one consecutive pediatric patients who underwent ASD (n = 43) or VSD (n = 18) repair via axillary thoracotomy between March 2017 and December 2023 were included. Patients were categorized by extubation timing into intraoperative (operating room [OR] group) and postoperative (intensive care unit [ICU] group). Baseline characteristics, operative variables, and postoperative outcomes were compared. Results: In the ASD cohort, patients extubated intraoperatively had a shorter hospital stay compared with those extubated in the ICU (2.78 +/- 1.24 vs. 3.60 +/- 0.99 days, P<0.001).In the VSD cohort, the ORgroup included youngerand lower-weight patients yet demonstrated a significantly shorter hospital stay (3.56 +/- 0.73 vs. 5.78 +/- 3.35 days, P = 0.013). Across the entire cohort, on-table extubation was associated with reduced hospital stay (P < 0.001), with no increase in reintubation or major complications. Conclusions: Intraoperative extubation following axillary thoracotomy for ASD and VSD repair in pediatric patients appears safe and feasible and was associated with a significantly shorter hospital stay, even in lower-weight patients. These findings suggest that intraoperative extubation may be considered as part of enhanced recovery strategies in pediatric congenital heart surgery.